Antipsychotic-like properties of 5-alpha-reductase inhibitors.
about
Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic ReviewThe neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gatingTargeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stressAnimal models of tic disorders: a translational perspective.Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation.The implication of neuroactive steroids in Tourette's syndrome pathogenesis: A role for 5α-reductase?Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice.Testosterone regulation of sex steroid-related mRNAs and dopamine-related mRNAs in adolescent male rat substantia nigraInhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activationAllopregnanolone mediates the exacerbation of Tourette-like responses by acute stress in mouse models.Gene-sex interactions in schizophrenia: focus on dopamine neurotransmission.5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric DisorderAdverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?What makes you tic? Translational approaches to study the role of stress and contextual triggers in Tourette syndrome.Finasteride inhibited brain dopaminergic system and open-field behaviors in adolescent male rats.Finasteride improves motor, EEG, and cellular changes in rat brain in thioacetamide-induced hepatic encephalopathy.The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep Deprivation.Prunella vulgaris attenuates prepulse inhibition deficit and attention disruption induced by MK-801 in mice.The role of estrogen and testosterone in female rats in behavioral models of relevance to schizophrenia.Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors.
P2860
Q28069186-BE87BB06-DDD3-48AC-8ABF-4E6823EDD45CQ30367021-31EF742B-9E6F-428B-A985-4A13BD0800E7Q30371274-37699171-8522-4A9A-B361-B6A701A61CE7Q30395243-7252D133-B9B6-44AA-815D-A224CE344C6CQ30422089-2796F3E2-E7C0-4ADC-8B53-36D4A44496B4Q30427160-D7E1E54B-A040-4BD9-8520-99FA00F903C4Q30440985-77FE34E6-EAA6-4DBA-97DA-B1AE36A94A05Q30462599-999F5981-0F02-42F1-926E-86DEAAB2EBB1Q30463310-B7DAA507-27C7-4307-8BAC-A1B18714314BQ33794211-68D7A099-40C3-4EEB-AEEA-A9E3FF8F5AD6Q34410670-AC69D211-A606-4942-8451-DC096FD147BDQ36565664-48403E0D-22ED-4834-BAB1-71F8DA9CABB0Q38571198-FDCF26E5-74F5-4181-B031-37D92B640D2BQ39035125-E5E9F012-2569-499C-9BBA-9DCEC07A1843Q47320877-9B3F2B88-22F5-4B24-9E3A-29F4DF99D2A6Q47741809-BA9B331A-AF6F-4BFC-8C55-8CAF155F9F3FQ47773133-B55170B1-3F41-4C84-9742-AF25CDBF7C76Q48194937-848CC8FD-6919-4C69-8D33-6063F61E9B13Q50792600-9346F2CA-A1E0-447E-BF6B-83B1572759B5Q53433418-9D37FDC4-87D9-44B1-984B-634EB66E129B
P2860
Antipsychotic-like properties of 5-alpha-reductase inhibitors.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Antipsychotic-like properties of 5-alpha-reductase inhibitors.
@en
Antipsychotic-like properties of 5-alpha-reductase inhibitors.
@nl
type
label
Antipsychotic-like properties of 5-alpha-reductase inhibitors.
@en
Antipsychotic-like properties of 5-alpha-reductase inhibitors.
@nl
prefLabel
Antipsychotic-like properties of 5-alpha-reductase inhibitors.
@en
Antipsychotic-like properties of 5-alpha-reductase inhibitors.
@nl
P2093
P2860
P356
P1476
Antipsychotic-like properties of 5-alpha-reductase inhibitors.
@en
P2093
Francesco Marrosu
Giampaolo Mereu
Gian L Gessa
Marco Orrù
Paola Devoto
Youri Bourov
P2860
P2888
P304
P356
10.1038/NPP.2008.39
P407
P577
2008-03-19T00:00:00Z